A bionic eye has been approved by the US Food and Drug Administration.
US regulators have approved an implant created by Second Sight Medical Products, Inc. that would help those living with retinitis pigmentosa. According to AFP, the rare genetic disease can often lead to blindness.
The FDA said in a statement:
“While the Argus II Retinal Prosthesis System will not restore vision to patients, it may allow them to detect light and dark in the environment, aiding them in identifying the location or movement of objects or people.”
Business Week explains that the bionic eye currently wears a price tag of around $100,000. The website describes the Argus II Retinal Prosthesis System as follows:
“The device consists of a video camera, a transmitter mounted on a pair of eyeglasses and a processing unit that transforms images into electronic data that is sent to an implanted retinal prosthesisThe device consists of a video camera, a transmitter mounted on a pair of eyeglasses and a processing unit that transforms images into electronic data that is sent to an implanted retinal prosthesis.”
The bionic eye has already been approved in Europe. Second Sight CEO Robert Greenberg now hopes he can help people in the United States who have been blinded by the genetic disease.
Greenberg called the Thursday’s approval a “game changer,” adding that the FDA’s decision “represents a huge step forward for the field and for these patients who were without any available treatment options until now.”
According to The Atlantic Wire, the bionic eye is already available to folks living in Europe. The device is expected to become available in the United States before the end of the year.
For detailed information about the bionic eye recently approved by the FDA and how it operates, be sure to stop by Popular Science.